Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications

Last updated: May 1, 2023
Sponsor: Thomas Jefferson University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pressure Ulcers

Treatment

PREVENA™ PEEL & PLACE™ Dressing Kit

Clinical Study ID

NCT03773575
18P.577
  • Ages > 18
  • All Genders

Study Summary

This study is a prospective, multi-center, two-arm, unblinded, and randomized controlled trial with a goal of evaluating the impact of a closed incision negative pressure dressing (PREVENA) on incidence of post-operative wound complications and medical costs in patients undergoing lower extremity amputation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Male or female adults 18 years or older
  2. Patients undergoing above-knee amputation (includes the revision of emergencyguillotine amputations)
  3. Patients undergoing below-knee amputation (includes the revision of emergencyguillotine amputations)
  4. Informed Consent signed by patient

Exclusion

Exclusion Criteria:

  1. Minors under 18 years
  2. Women who are pregnant or breastfeeding
  3. Patients undergoing emergent or guillotine amputation
  4. Patients having BOTH legs amputated
  5. Patients with sensitivity to silver
  6. Unwilling or unable to provide informed consent
  7. Inability to comply with planned study procedures

Study Design

Total Participants: 440
Treatment Group(s): 1
Primary Treatment: PREVENA™ PEEL & PLACE™ Dressing Kit
Phase:
Study Start date:
January 15, 2019
Estimated Completion Date:
August 15, 2024

Study Description

This is a prospective, multi-center, two-arm, unblinded, randomized controlled trial to evaluate the impact of a closed incision negative pressure dressing (PREVENA™ PEEL & PLACE™ Dressing Kit) on incidence of post-operative wound complications in patients undergoing above-the-knee (AKA) or below-the-knee (BKA) amputation. Up to 440 subjects at approximately five (5) participating sites will be randomized to receive either the Prevena dressing or a standard care dressing. The incision will be assessed for complications at post-op day 5 or day 6 and at approximately 30 days after discharge. The primary outcome of this study is reported wound complications, including dehiscence (opening of the incision), seroma, lymph leak, infection (deep or superficial), hematoma (blood clots), ischemia (decreased blood supply), and necrosis (tissue death) A major complication is defined as any wound complication requiring intravenous or oral antibiotics, reoperation and/or hospital readmission. All data (demographics, medical history, and clinical outcomes) will be collected via medical record review

Connect with a study center

  • Gemelli Hospital

    Roma, RM 8, 00168
    Italy

    Active - Recruiting

  • Kaleida Health - Buffalo General Medical Center

    Buffalo, New York 14203
    United States

    Site Not Available

  • Upstate University Hospital

    Syracuse, New York 13210
    United States

    Site Not Available

  • Westchester Medical Center

    Valhalla, New York 10595
    United States

    Active - Recruiting

  • Abington Hospital

    Abington, Pennsylvania 19001
    United States

    Site Not Available

  • Thomas Jefferson University/Hospital

    Philadelphia, Pennsylvania 19107
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.